User profiles for "author:Pintip Ngamjanyaporn"
 | Pintip NgamjanyapornMahidol University Verified email at mahidol.ac.th Cited by 660 |
Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis
We performed a systematic review and meta-analysis of randomized controlled trials to
compare complete remission and adverse events (that is, infection, leukopenia, and …
compare complete remission and adverse events (that is, infection, leukopenia, and …
Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases
P Vananuvat, P Suwannalai, S Sungkanuparph… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVES: The aim of our study was to examine the primary prophylactic effect of
sulfamethoxazole/trimethoprim single strength (SMZ/TM SS) against Pneumocystis jirovecii …
sulfamethoxazole/trimethoprim single strength (SMZ/TM SS) against Pneumocystis jirovecii …
[HTML][HTML] Performance of cytokine models in predicting SLE activity
N Ruchakorn, P Ngamjanyaporn, T Suangtamai… - Arthritis research & …, 2019 - Springer
Background Identification of universal biomarkers to predict systemic lupus erythematosus
(SLE) flares is challenging due to the heterogeneity of the disease. Several biomarkers have …
(SLE) flares is challenging due to the heterogeneity of the disease. Several biomarkers have …
[HTML][HTML] Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations
JA Reynolds, EM McCarthy, S Haque… - Arthritis research & …, 2018 - Springer
Background Patients with SLE display marked clinical and immunlogical heterogeneity. The
purpose of the study was to investigate patterns of serum cytokines in patients with active …
purpose of the study was to investigate patterns of serum cytokines in patients with active …
[HTML][HTML] Nonscarring alopecia in systemic lupus erythematosus: a cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses
K Chanprapaph, S Udompanich, Y Visessiri… - Journal of the American …, 2019 - Elsevier
Background Nonscarring alopecia in systemic lupus erythematosus (SLE) is widely
recognized, but reports on its clinical, trichoscopic, histopathologic, and direct …
recognized, but reports on its clinical, trichoscopic, histopathologic, and direct …
[HTML][HTML] The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus
C Thanadetsuntorn, P Ngamjanyaporn… - Scientific Reports, 2018 - nature.com
Abstract Systemic Lupus Erythematosus (SLE) is an autoimmune disease resulting in
autoantibody production, immune complex deposition, and complement activation. The …
autoantibody production, immune complex deposition, and complement activation. The …
[HTML][HTML] Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or …
Introduction There is a need for sensitive and specific biomarkers to predict kidney damage
and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP …
and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP …
Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-γ autoantibodies
W Laisuan, P Pisitkun, P Ngamjanyaporn… - Open Forum …, 2020 - academic.oup.com
Background Adult-onset immunodeficiency associated with interferon-γ autoantibody (IGA)
is an emerging disease. The majority of patients require both antimicrobial and …
is an emerging disease. The majority of patients require both antimicrobial and …
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey
P Ngamjanyaporn, EM McCarthy… - Lupus Science & …, 2017 - lupus.bmj.com
Background The definition of remission in systemic lupus erythematosus (SLE) remains
unclear, especially how background treatment should be interpreted. Objective To …
unclear, especially how background treatment should be interpreted. Objective To …
[HTML][HTML] Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population
Background Differences in the expression of variants across ethnic groups in the systemic
lupus erythematosus (SLE) patients have been well documented. However, the genetic …
lupus erythematosus (SLE) patients have been well documented. However, the genetic …